EG23929A - Isoxazolines derivatives and their use as antidepressants - Google Patents

Isoxazolines derivatives and their use as antidepressants

Info

Publication number
EG23929A
EG23929A EG20020197A EG20020197A EG23929A EG 23929 A EG23929 A EG 23929A EG 20020197 A EG20020197 A EG 20020197A EG 20020197 A EG20020197 A EG 20020197A EG 23929 A EG23929 A EG 23929A
Authority
EG
Egypt
Prior art keywords
antidepressants
isoxazolines
derivatives
isoxazolines derivatives
Prior art date
Application number
EG20020197A
Other languages
English (en)
Inventor
Jose I Andres-Gil
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of EG23929A publication Critical patent/EG23929A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/20Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
EG20020197A 2001-02-21 2002-02-19 Isoxazolines derivatives and their use as antidepressants EG23929A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01200611 2001-02-21
EP01201264 2001-04-05

Publications (1)

Publication Number Publication Date
EG23929A true EG23929A (en) 2008-01-14

Family

ID=26076836

Family Applications (1)

Application Number Title Priority Date Filing Date
EG20020197A EG23929A (en) 2001-02-21 2002-02-19 Isoxazolines derivatives and their use as antidepressants

Country Status (33)

Country Link
US (1) US7169786B2 (de)
EP (1) EP1368358B1 (de)
JP (1) JP3953424B2 (de)
KR (1) KR100848898B1 (de)
CN (1) CN100400540C (de)
AR (1) AR035685A1 (de)
AT (1) ATE337322T1 (de)
AU (1) AU2002244717B2 (de)
BG (1) BG107984A (de)
BR (1) BR0207433A (de)
CA (1) CA2437505C (de)
CY (1) CY1106448T1 (de)
CZ (1) CZ20032515A3 (de)
DE (1) DE60214138T2 (de)
DK (1) DK1368358T3 (de)
EA (1) EA006747B1 (de)
EE (1) EE200300398A (de)
EG (1) EG23929A (de)
ES (1) ES2271230T3 (de)
HK (1) HK1065537A1 (de)
HR (1) HRP20030647A2 (de)
HU (1) HUP0303270A3 (de)
IL (2) IL157470A0 (de)
MX (1) MXPA03007432A (de)
MY (1) MY137836A (de)
NO (1) NO20033700L (de)
NZ (1) NZ526741A (de)
PL (1) PL208593B1 (de)
PT (1) PT1368358E (de)
SI (1) SI1368358T1 (de)
SK (1) SK11612003A3 (de)
TW (1) TWI257392B (de)
WO (1) WO2002066484A1 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203299D0 (en) * 2002-02-12 2002-03-27 Glaxo Group Ltd Novel compounds
WO2003082878A1 (en) 2002-04-02 2003-10-09 Janssen Pharmaceutica N.V. Substituted amino isoxazoline derivatives and their use as anti-depressants.
TW200409777A (en) * 2002-08-12 2004-06-16 Janssen Pharmaceutica Nv C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
JP4478571B2 (ja) * 2002-08-15 2010-06-09 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ 縮合複素環式イソオキサゾリン誘導体及び抗うつ薬としてのそれらの使用
ES2301816T3 (es) * 2002-08-21 2008-07-01 Janssen Pharmaceutica Nv Derivados de cromeno(4,3,c)isoxazolina sustituidos en c6 y c9 y su uso como antidepresivos.
ZA200507486B (en) 2003-03-07 2007-03-28 Astellas Pharma Inc Nitrogenous heterocyclic derivative having 2,6-disubstituted styryl
EP1944306A1 (de) * 2003-09-17 2008-07-16 Janssen Pharmaceutica, N.V. Fusionierte heterocyclische Verbindungen
ES2319539T3 (es) * 2003-09-17 2009-05-08 Janssen Pharmaceutica Nv Compuestos heterociclicos condensados como moduladores del receptor de serotonina.
DE602005016836D1 (de) * 2004-11-26 2009-11-05 Janssen Pharmaceutica Nv Chotischer und anxiolytischer aktivität
SG10201506994RA (en) * 2007-03-09 2015-10-29 Sanofi Aventis Substituted dihydro and tetrahydro oxazolopyrimidinones, preparation and use thereof
CA2688405A1 (en) * 2007-06-08 2008-12-18 Helicon Therapeutics, Inc. Therapeutic pyrazoloquinoline urea derivatives
WO2009082268A2 (ru) 2007-12-21 2009-07-02 Alla Chem, Llc ЛИГАНДЫ α-АДРЕНОЦЕПТОРОВ, ДОПАМИНОВЫХ, ГИСТАМИНОВЫХ, ИМИДАЗОЛИНОВЫХ И СЕРОТОНИНОВЫХ РЕЦЕПТОРОВ И ИХ ПРИМЕНЕНИЕ
AR078171A1 (es) 2009-09-15 2011-10-19 Sanofi Aventis Dihidrobenzocicloalquiloximetil-oxazolopirimidinonas sustituidas, preparacion y uso de las mismas

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0361577B1 (de) * 1988-09-19 1993-05-05 Akzo N.V. Tetrahydronaphthalin und Indan-Derivate
US5880121A (en) * 1996-01-05 1999-03-09 Hoechst Marion Roussel Inc. 4,5-dihydronaphth (1,2-c) isoxazoles and derivatives thereof
ES2182064T3 (es) * 1996-04-12 2003-03-01 Janssen Pharmaceutica Nv Derivados de isoxazolidina.
HUP9602763A3 (en) * 1996-10-09 1999-05-28 Egyt Gyogyszervegyeszeti Gyar 3-phenyl isoxazole derivatives, process for producing them and pharmaceutical compositions containing the same
CA2346396C (en) * 1998-10-09 2009-04-28 Janssen Pharmaceutica N.V. 4,5-dihydro-isoxazole derivatives and their pharmaceutical use

Also Published As

Publication number Publication date
HK1065537A1 (en) 2005-02-25
CN1492871A (zh) 2004-04-28
KR100848898B1 (ko) 2008-07-29
CZ20032515A3 (cs) 2003-12-17
MY137836A (en) 2009-03-31
SK11612003A3 (sk) 2004-04-06
BG107984A (bg) 2004-09-30
HRP20030647A2 (en) 2005-06-30
PT1368358E (pt) 2007-01-31
EA200300915A1 (ru) 2004-06-24
CN100400540C (zh) 2008-07-09
US7169786B2 (en) 2007-01-30
MXPA03007432A (es) 2003-11-18
US20040122037A1 (en) 2004-06-24
CY1106448T1 (el) 2011-10-12
AU2002244717B2 (en) 2007-07-19
DE60214138T2 (de) 2007-03-29
SI1368358T1 (sl) 2007-02-28
EP1368358B1 (de) 2006-08-23
EA006747B1 (ru) 2006-04-28
NZ526741A (en) 2004-04-30
DK1368358T3 (da) 2007-01-02
EE200300398A (et) 2003-12-15
CA2437505C (en) 2010-02-09
PL363264A1 (en) 2004-11-15
BR0207433A (pt) 2004-06-01
NO20033700D0 (no) 2003-08-20
JP2004518748A (ja) 2004-06-24
AR035685A1 (es) 2004-06-23
CA2437505A1 (en) 2002-08-29
IL157470A0 (en) 2004-03-28
PL208593B1 (pl) 2011-05-31
WO2002066484A1 (en) 2002-08-29
ES2271230T3 (es) 2007-04-16
HUP0303270A2 (hu) 2004-01-28
DE60214138D1 (de) 2006-10-05
NO20033700L (no) 2003-10-21
KR20030076590A (ko) 2003-09-26
JP3953424B2 (ja) 2007-08-08
ATE337322T1 (de) 2006-09-15
HUP0303270A3 (en) 2007-03-28
IL157470A (en) 2008-07-08
EP1368358A1 (de) 2003-12-10
TWI257392B (en) 2006-07-01

Similar Documents

Publication Publication Date Title
HK1078266A1 (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same
SI1757606T1 (sl) Ksantinski derivati za uporabo kot zdravila kot tudi postopek za njihovo pripravo
SI1427711T1 (sl) Oksazolidinonski in/ali izoksazolinski derivati kot antibakterijska sredstva
EP1367060A4 (de) Glukopyranosyloxybenzylbenzolderivate und deren medizinische verwendung
EP1364957A4 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
HK1083831A1 (en) Indazoles, benzothiazoles, and benzoisothiazoles, and preparation and uses thereof
EP1364958A4 (de) Glykopyranosyloxypyrazolderivate und deren medizinische verwendung
HK1068555A1 (en) New formulations and use thereof
ZA200204020B (en) Use of anti-CTLA-4-antibodies.
HUP0401335A3 (en) Herbicidal pyridylpropynyloxyphenyl derivatives, preparation and use thereof
HUP0300268A3 (en) Herbicidal benzoylpyrazole derivatives, compositions containing the same and their use
DE60208622D1 (de) Siliciumoxidpulver und dessen Herstellung
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
IL156161A0 (en) Substituted 2-anilino-benzimidazoles and the use thereof as nhe-inhibitors
HK1081954A1 (en) Novel 1,4-diazabicycloalkane derivatives, their preparation and use
IL155520A0 (en) Benzoxazinone derivatives, their preparation and use
EG23929A (en) Isoxazolines derivatives and their use as antidepressants
HUP0401092A3 (en) 5-halogen-6-phenyl-7-fluoralkylamino-triazolopyrimidines as fungicides, preparation and use thereof
ZA200309513B (en) Novel heterocyclic derivatives and medicinal use thereof.
IL158056A0 (en) Chemical derivatives and their use as anti-telomerase agent
MXPA03001826A (es) Derivados de arilpiperazina.
SI1532141T1 (sl) 2-pirolidin-2-il-(1,3,4)-oksadiazolni derivati in njihova uporaba kot antidepresivi
HUP0600238A2 (en) Benzothiazole- and benzoxazole-4,7-dione derivatives and their use
HK1066022A1 (en) Use of 1,1,1,3,3-pentafluorobutan
EP1367123A4 (de) Neurotonin und dessen verwendung